ID

31875

Beschrijving

A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to Methotrexate; ODM derived from: https://clinicaltrials.gov/show/NCT00845832

Link

https://clinicaltrials.gov/show/NCT00845832

Trefwoorden

Versies (1)
  1. 05-10-18 05-10-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

5 oktober 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Rheumatoid Arthritis NCT00845832

Engels

Eligibility Rheumatoid Arthritis NCT00845832

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, 18-65 years of age;
Beschrijving

Adult | Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
rheumatoid arthritis, functional status i-iii;
Beschrijving

Rheumatoid Arthritis Functional Status Class

Datatype

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0598463
UMLS CUI [1,3]
C0456387
sjc>=4 (28 joint count) and tjc>=4 (28 joint count) at screening and baseline;
Beschrijving

Swollen 28 joint count | Tender 28 joint count

Datatype

boolean

Alias
UMLS CUI [1]
C2711873
UMLS CUI [2]
C2711398
rf and/or anti-ccp positive;
Beschrijving

Rheumatoid factor positive | Anti-cyclic citrullinated peptide antibody positive

Datatype

boolean

Alias
UMLS CUI [1]
C0151379
UMLS CUI [2]
C2609056
may have failed up to 1 approved anti-tnf agent (infliximab, etanercept or adalimumab);
Beschrijving

Anti-tumor necrosis factor alpha drug Quantity failed | infliximab | Etanercept | adalimumab

Datatype

boolean

Alias
UMLS CUI [1,1]
C1562242
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
UMLS CUI [2]
C0666743
UMLS CUI [3]
C0717758
UMLS CUI [4]
C1122087
inadequate response to methotrexate, at a dose of 7.5-25mg weekly for at least 12 weeks, at a stable dose for past 4 weeks.
Beschrijving

Methotrexate Dose Stable U/week | Response Inadequate

Datatype

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0560588
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C0205412
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
rheumatic autoimmune disease other than rheumatoid arthritis, or significant systemic involvement secondary to rheumatoid arthritis;
Beschrijving

Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis | Rheumatoid arthritis with systemic involvement

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0035435
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003873
UMLS CUI [3]
C0494896
history of, or current, inflammatory joint disease other than rheumatoid arthritis;
Beschrijving

Inflammatory joint disease | Exception Rheumatoid Arthritis

Datatype

boolean

Alias
UMLS CUI [1]
C0683381
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003873
diagnosis of juvenile idiopathic arthritis and/or rheumatoid arthritis before age 16;
Beschrijving

Juvenile arthritis | Juvenile rheumatoid arthritis | Age

Datatype

boolean

Alias
UMLS CUI [1]
C3495559
UMLS CUI [2]
C3714757
UMLS CUI [3]
C0001779
significant cardiac or pulmonary disease;
Beschrijving

Heart Disease | Lung disease

Datatype

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0024115
previous treatment with any biologic agent for rheumatoid arthritis (other than infliximab, etanercept or adalimumab).
Beschrijving

Biological agent Rheumatoid Arthritis | Exception Infliximab | Exception Etanercept | Exception Adalimumab

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005515
UMLS CUI [1,2]
C0003873
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0666743
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0717758
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1122087
Terug naar het begin van de pagina

Similar models

Eligibility Rheumatoid Arthritis NCT00845832

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, 18-65 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Rheumatoid Arthritis Functional Status Class
Item
rheumatoid arthritis, functional status i-iii;
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Swollen 28 joint count | Tender 28 joint count
Item
sjc>=4 (28 joint count) and tjc>=4 (28 joint count) at screening and baseline;
boolean
C2711873 (UMLS CUI [1])
C2711398 (UMLS CUI [2])
Rheumatoid factor positive | Anti-cyclic citrullinated peptide antibody positive
Item
rf and/or anti-ccp positive;
boolean
C0151379 (UMLS CUI [1])
C2609056 (UMLS CUI [2])
Anti-tumor necrosis factor alpha drug Quantity failed | infliximab | Etanercept | adalimumab
Item
may have failed up to 1 approved anti-tnf agent (infliximab, etanercept or adalimumab);
boolean
C1562242 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0666743 (UMLS CUI [2])
C0717758 (UMLS CUI [3])
C1122087 (UMLS CUI [4])
Methotrexate Dose Stable U/week | Response Inadequate
Item
inadequate response to methotrexate, at a dose of 7.5-25mg weekly for at least 12 weeks, at a stable dose for past 4 weeks.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis | Rheumatoid arthritis with systemic involvement
Item
rheumatic autoimmune disease other than rheumatoid arthritis, or significant systemic involvement secondary to rheumatoid arthritis;
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0494896 (UMLS CUI [3])
Inflammatory joint disease | Exception Rheumatoid Arthritis
Item
history of, or current, inflammatory joint disease other than rheumatoid arthritis;
boolean
C0683381 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
Juvenile arthritis | Juvenile rheumatoid arthritis | Age
Item
diagnosis of juvenile idiopathic arthritis and/or rheumatoid arthritis before age 16;
boolean
C3495559 (UMLS CUI [1])
C3714757 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Heart Disease | Lung disease
Item
significant cardiac or pulmonary disease;
boolean
C0018799 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
Biological agent Rheumatoid Arthritis | Exception Infliximab | Exception Etanercept | Exception Adalimumab
Item
previous treatment with any biologic agent for rheumatoid arthritis (other than infliximab, etanercept or adalimumab).
boolean
C0005515 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0666743 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0717758 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1122087 (UMLS CUI [4,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial